Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
for
Depressive Disorder, Major
Location: Washington D.C. DC, Baltimore MD, Chapel Hill NC,
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Washington D.C. DC, Baltimore MD, Hackensack NJ,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT07110246
Phase 2, Recruiting
Combatting HIV Or Other STIs Early (CHOOSE)
for
HIV, STIs, STIs Prevention, HIV Prevention
Location: Washington D.C. DC, Chicago IL, Memphis TN, Tampa FL,
Sponsor: Westat
Sex: Male
Age: 13 - 24
Code: NCT07510048
Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Washington D.C. DC, Toronto, Montreal, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT04901702
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: Washington D.C. DC, Baltimore MD, King of Prussia PA,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
for
GRIN-related Neurodevelopmental Disorder
Location: Washington D.C. DC, Philadelphia PA, Hackensack NJ,
Sponsor: GRIN Therapeutics, Inc.
Sex: All
Age: 0 - 18
Code: NCT07224581
Phase 3, Recruiting
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
for
Medulloblastoma, Medulloblastoma, Childhood,
Location: Washington D.C. DC, Seattle WA
Sponsor: Sabine Mueller, MD, PhD
Sex: All
Age: 1 - 25
Code: NCT07346157
Phase 1, Phase 2, Recruiting
Empowering Young Parents: Building Healthy Relationships Study
for
Gender-based Violence, Intimate Partner Violence
Location: Washington D.C. DC, Camden DE, Georgetown DE,
Sponsor: RTI International
Sex: Female
Age: 14 - 21
Code: NCT06576193
Recruiting
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
for
Allergic Reactions
Location: Washington D.C. DC, New York NY, Cincinnati OH,
Sponsor: ARS Pharmaceuticals, Inc.
Sex: All
Age: 4+
Code: NCT06834165
Recruiting
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
for
Duchene Muscular Dystrophy
Location: Washington D.C. DC, New York NY, Durham NC,
Sponsor: ITF Therapeutics LLC
Sex: All
Age: 6+
Code: NCT07127978
Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
for
Short Bowel Syndrome
Location: Washington D.C. DC, Boston MA, Cincinnati OH,
Sponsor: Eclipse Regenesis, Inc.
Sex: All
Age: 0 - 65
Code: NCT05535361
Recruiting
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 1 - 8
Code: NCT06188741
Phase 2, Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Washington D.C. DC, Hershey PA, Waterford MI,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase 3, Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase 2, Recruiting
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
Location: Washington D.C. DC, Columbus OH, Toronto, Cincinnati OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT06838676
Phase 2, Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
for
Heterozygous Familial Hypercholesterolemia (HeFH)
Location: Washington D.C. DC, Wilmington DE, Morgantown WV,